Paid Clinical Trials in Kirkland, WA
As of August 2026, 41 paid clinical trials are recruiting in Kirkland, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Kirkland offers studies at sites including FHCC at EvergreenHealth for conditions such as Parkinson Disease, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Kirkland
Trials by drug in Kirkland
Filter results
Newly added in Kirkland
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
38 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
An Observational Study of Individuals With Isolated Dystonia
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Parkinson's Foundation PD GENEration Genetic Registry
Pridopidine Phase 3 Study in Huntington's Disease
Top Research Study Locations in Kirkland
Researchers run research studies in Kirkland, WA at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| FHCC at EvergreenHealth | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 11 |
| EvergreenHealth | Lewy Body Dementia Psychosis, Amyloid, Cognitive Dysfunction | 4 |
| Evergreen Health | Parkinson's Disease, Degenerative Disc Disease, Spondylolisthesis | 3 |
| EvergreenHealth Medical Center | Alzheimer's Disease, Multiple Sclerosis Spasticity | 2 |
| EvergreenHealth Research Department, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Paramount Clinical Research - Data Point Clinical Research | Osteoarthritis, Overweight or Obesity, Pulmonary Disease, Chronic Obstructive | 2 |
| TG Therapeutics Investigational Trial Site | Relapsing Multiple Sclerosis, Multiple Sclerosis | 2 |
| Vima | Dystonia, Isolated/Primary Dystonia That Affects More Than One Region of the Body | 2 |
| Booth Gardner Parkinson's Care Center (Evergreen Health) | Huntington's Disease | 1 |
| Data Point Clinical, LLC | Obesity, Overweight | 1 |
| Evergreen Health Research | Parkinson Disease | 1 |
| Evergreen Health Research Program | Parkinson's Disease With Freezing of Gait | 1 |
| EvergreenHealth | Parkinson Disease | 1 |
| EvergreenHealth - Research Department | Parkinsons Disease (PD) | 1 |
| EvergreenHealth Research Department | Huntington Disease | 1 |
| EvergreenHealth Research Department (Neurology) | Parkinson Disease | 1 |
| Eye Associates Northwest - Kirkland Clinic | Advanced/Metastatic Urothelial Cancer, Urothelial Cancer, Urothelial Carcinoma | 1 |
| Fred Hutch CC at Evergreen HMC | Breast Cancer | 1 |
| Local Institution - 1254 | Psychosis Associated With Alzheimer's Disease | 1 |
| Proliance Eastside Surgery Center | Lumbar Spinal Stenosis | 1 |
| Seattle Cancer Care Alliance at EvergreenHealth | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
Active & Upcoming Studies in Kirkland (2026)
Recruiting trials in Kirkland grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · Phase 3 · National Cancer Institute (NCI)
Neurology & pain (9 active studies)
- A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations · Phase 2 · Appello Pharmaceuticals, Inc.
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine · Phase 3 · Merz Therapeutics GmbH
Diabetes & metabolic (2 active studies)
- A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight · Phase 2 · Boehringer Ingelheim
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight · Phase 3 · Eli Lilly and Company
Common conditions studied in Kirkland
- Parkinson Disease (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (2 active studies)
- Breast Cancer (2 active studies)
- Early Stage Triple-Negative Breast Carcinoma (2 active studies)
Leading research sponsors in Kirkland
- Eli Lilly and Company
- SWOG Cancer Research Network
- ACADIA Pharmaceuticals Inc.
- Canadian Cancer Trials Group
- Merz Therapeutics GmbH
Frequently asked questions
How many paid clinical trials are currently recruiting in Kirkland?
There are approximately 41 recruiting clinical trials in Kirkland, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Kirkland pay participants?
Most recruiting trials in Kirkland compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Kirkland?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Kirkland?
The most common conditions under active study in Kirkland include Parkinson Disease (4), Anatomic Stage II Breast Cancer AJCC v8 (2), Anatomic Stage IIIA Breast Cancer AJCC v8 (2), Anatomic Stage IIIB Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Kirkland?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kirkland on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Kirkland?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Kirkland?
Recruiting research sites in Kirkland include FHCC at EvergreenHealth, EvergreenHealth, Evergreen Health, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Kirkland right now?
The largest active categories in Kirkland are Cancer & tumors (14), Neurology & pain (9), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.